Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data
- PMID: 34156698
- DOI: 10.26355/eurrev_202106_26060
Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data
Abstract
Objective: As a beta-coronavirus, Coronavirus disease-2019 (COVID-19) has caused one of the most significant historical pandemics, as well as various health and medical challenges. Our purpose in this report is to collect, summarize, and articulate all essential information about antiviral drugs that may or may not be efficient for treating COVID-19. Clinical evidence about these drugs and their possible mechanisms of action are also discussed.
Materials and methods: To conduct a comprehensive review, different keywords in various databases, including Web of Science, Scopus, Medline, PubMed, and Google Scholar, were searched relevant articles, especially the most recent ones, were selected and studied. These selected original research articles, review papers, systematic reviews, and even letters to the editors were then carefully reviewed for data collection.
Results: SARS-CoV-2 is the newest member of the coronavirus family, and there are still no promising therapies or particular antiviral compounds to fight it. After entering the body, SARS-CoV-2 penetrates the cells by attaching to specific lung cell receptors, called angiotensin-converting enzyme-2. Then, by employing cell division machinery, it replicates through a complex mechanism and spreads throughout the patient's body. Various antiviral drugs, including anti-influenza/HIV/HCV drugs, have been applied for treating COVID-19 patients. Due to the similarity of the structure and transcriptional mechanism of COVID-19 to a number of viruses, some of the listed drugs have been beneficial against SARS-CoV-2. However, the effectiveness of others is in an aura of ambiguity and doubt.
Conclusions: Some of the antiviral medications listed and discussed in this article have been effective in the treatment of COVID-19 patients or preventing the virus from spreading further. However, other drugs have to be investigated to reach a reliable conclusion about their effectiveness or ineffectiveness.
Similar articles
-
Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.Phytother Res. 2020 Dec;34(12):3137-3147. doi: 10.1002/ptr.6781. Epub 2020 Jul 2. Phytother Res. 2020. PMID: 32613637 Free PMC article. Review.
-
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?Cell Cycle. 2021 Jan;20(2):143-153. doi: 10.1080/15384101.2020.1867792. Epub 2020 Dec 31. Cell Cycle. 2021. PMID: 33382348 Free PMC article. Review.
-
Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.Comb Chem High Throughput Screen. 2021;24(3):441-454. doi: 10.2174/1386207323999200730205447. Comb Chem High Throughput Screen. 2021. PMID: 32748740
-
Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.J Cell Physiol. 2021 Apr;236(4):2364-2392. doi: 10.1002/jcp.30032. Epub 2020 Sep 9. J Cell Physiol. 2021. PMID: 32901936
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
Cited by
-
Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features.Mol Cell Biochem. 2022 Mar;477(3):711-726. doi: 10.1007/s11010-021-04325-9. Epub 2022 Jan 11. Mol Cell Biochem. 2022. PMID: 35013850 Free PMC article. Review.
-
Effectiveness of Fortified Garlic Extract Oral Capsules as Adjuvant Therapy in Hospitalized Patients with Coronavirus Disease 2019: A Triple-Blind Randomized Controlled Clinical Trial.Curr Ther Res Clin Exp. 2023;98:100699. doi: 10.1016/j.curtheres.2023.100699. Epub 2023 Mar 14. Curr Ther Res Clin Exp. 2023. PMID: 36998289 Free PMC article.
-
Antivirals in COVID-19: A Focus on Pediatric Cardiac Patients.Can J Infect Dis Med Microbiol. 2025 Mar 30;2025:4573096. doi: 10.1155/cjid/4573096. eCollection 2025. Can J Infect Dis Med Microbiol. 2025. PMID: 40196380 Free PMC article. Review.
-
Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial.BMC Pharmacol Toxicol. 2024 Oct 17;25(1):78. doi: 10.1186/s40360-024-00781-3. BMC Pharmacol Toxicol. 2024. PMID: 39420385 Free PMC article. Clinical Trial.
-
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Management of Mild-to-Moderate Symptomatic COVID-19.Med Sci Monit. 2022 Mar 8;28:e936292. doi: 10.12659/MSM.936292. Med Sci Monit. 2022. PMID: 35256581 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous